Carna Biosciences, Inc. (4572.T) JPX

227.00

+2(+0.89%)

Updated at August 18 03:30PM

Currency In JPY

Valuation

Market Cap5.37B
Enterprise Value3.33B
P/E Ratio-1.9
PEG Ratio0.81
Price/Sales Ratio7.24
Price/Book Ratio2.22
Enterprise/Revenue4.72
Enterprise/EBITDA-1.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-3.8
Operating Margin-3.6

Management Effectiveness

Return On Assets-1.05
Return On Equity-0.88

Income Statement

Revenue636.24M
Revenue/Share31.39
Gross Profit465.69M
EBITDA-2.14B
Net Income-2.18B
Diluted EPS-121.64

Balance Sheet

Total Cash1.53B
Total Cash/Share80.09
Total Debt23.4M
Total Debt/Equity0.01
Current Ratio14.1
Book Value Per Share102.43

Price History

52-Week Change-44.09
52-Week High482
52-Week Low216
Moving Average 50 Days311.8
Moving Average 200 Days294.29

Statistics

Average Volume202,636
Shares Outstanding19.1M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor100:1
Last Split DateDecember 26, 2013